Effect of enalapil on renal interstitial fibrosis in rats with unilateral ureteral obstruction

Journal of Central South University (Medical Sciences)

Volumn 33, Issue 9, 2008, Pages 841-848

  Wang, Lin Na ^a   Tao, Li Jian ^a   Ning, Wang Bin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Connective tissue growth factor; Renal interstitial fibrosis; Unilateral ureter obstruction

Indexed keywords

COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, RAT; ENALAPRIL; MESSENGER RNA;

ANIMAL; ARTICLE; BIOSYNTHESIS; GENETICS; INTERSTITIAL NEPHRITIS; MALE; NEPHROSCLEROSIS; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; URETER OBSTRUCTION;

ANIMALS; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; ENALAPRIL; MALE; NEPHRITIS, INTERSTITIAL; NEPHROSCLEROSIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; URETERAL OBSTRUCTION;

EID: 53649106035     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Klahr S, Ishidoya S, Morrissey J. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy [J]. Am J Kidney Dis, 1995, 26(1):141-146.
2. Kellner D, Chen J, Richardson I, et al. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction [J]. J Urol, 2006, 176(2):806-812.
3. Turan T, van Harten J G, de Water R, et al. Is enalapril adequate for the prevention of renal tissue damage caused by unilateral ureteral obstruction and/or hyperoxaluria? [J]. Urol Res, 2003, 31(3):212-217.
4. Radford G, Donadio J V, Bergstralh E J, et al. Predicting renal outcoming in IgA nephropathy [J]. J Am Soc Nephrol, 1997, 8(2):199-207.
5. Wu M J, Wen M C, Chiu Y T, et al. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis [J]. Kidney Int, 2006, 69(11):2029-2036.
6. Werbrock H, Bottelboom N, Uyttendaele M, et al. Quantification of gene expression of Listeria monocytogenes by real-time reverse transcription PCR: optimization, evaluation and pitfalls [J]. J Microbiol Methods, 2007, 9(2):306-314.
7. O'Neill H J, McCaughey C, Coyle P V, et al. Cinical utility of nested multiplex RT-PCR for group F adenovirus, rotavirus and norwalk-like viruses in acute viral gastroenteritis in children and adults [J]. J Clin Virol, 2002, 25(3):335-338.
8. Hirschberg R. Wound healing in the kidney: complex interactions in renal interstitial fibrogenesis [J]. J Am Soc Nephrol, 2005, 16(1):9-11.
9. Eddy A A. Progression in chronic kidney disease [J]. Adv Chronic Kidney Dis, 2005, 12(1):353-365.
10. Diamond J R, Ricardo S D, Klahr S. Mechanisms of interstitial fibrosis in obstructive nephropathy [J]. Semin Nephrol, 1998, 18(6):594-602.
11. Pimentel J L Jr, Sundell C L, Wang S, et al. Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy [J]. Kidney Int, 1995, 48(4):1233-1246.
12. Klahr S, Morrissey J J. The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy [J]. Semin Nephrol, 1998, 18(6):622-632.
13. Klahr S, Ishidoya S, Morrissey J. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy [J]. Am J Kidney Dis, 1995, 26(1):141-146.
14. Guo G, Morrissey J, McCracken R, et al. Contributions of angiotensin II and tumor necrosis factor-α to the development of renal fibrosis [J]. Am J Physiol Renal Physiol, 2001, 280(5):F777-F785.
15. Kaneto H, Morrissey J, McCracken R, et al. Enalapril reduces collagen Type IV synthesis and expansion of the interstitium in the obstructed rat kidney [J]. Kidney Int, 1994, 45(6):1637-1647.
16. Ishidoya S, Morrissey J, McCracken R, et al. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy [J]. Kidney Int, 1996, 49(4):1110-1119.
17. Kaneto H, Morrissey J, Klahr S. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation [J]. Kidney Int, 1993, 44(2):313-321.
18. Noda M, Fukuda R, Matsuo T, et al. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats [J]. Kidney Int, 1997, 63(12):S136-139.
19. Okada K, Okawa E, Shibahara H, et al. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure [J]. Kidney Blood Press Res, 2004, 27(4):218-225.
20. Abbate M, Zoja C, Rottoti D, et al. Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts [J]. Kidney Int, 2002, 61(6):2066-2077.
21. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis [J]. Am J Physiol Renal Physiol, 2002, 283(5):F861-875.